BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18556065)

  • 1. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
    Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
    Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic survey of 117 Tunisian patients with de novo myelodysplastic syndrome.
    Sendi HS; Hichri H; Elghezal H; Gribaa M; Laatiri A; Elloumi M; Ben Lakhal R; Saad A
    Ann Genet; 2002; 45(3):131-5. PubMed ID: 12381443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings.
    Parlier V; van Melle G; Beris P; Schmidt PM; Tobler A; Haller E; Bellomo MJ
    Cancer Genet Cytogenet; 1994 Dec; 78(2):219-31. PubMed ID: 7828157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K; Mori H; Niikura H; Terada H; Shinohara T
    Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
    Suciu S; Kuse R; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
    Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
    Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
    Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
    Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic findings in primary and secondary MDS.
    Heim S
    Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
    Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
    Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
    Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.